Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Reid

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2016
An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in MiceAnh Do, Robert C Reid, Rink-Jan Lohman, et al.
Journal of Innate Immunity|March 7, 2023
Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human MacrophagesKai-Chen Wu, Nicholas D Condon, Timothy A Hill, et al.
Journal of Medicinal Chemistry|September 30, 2010
Novel agonists and antagonists for human protease activated receptor 2Grant D Barry, Jacky Y Suen, Giang T Le, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive ratsScott Levick, David Loch, Barbara Rolfe, et al.
British Journal of Pharmacology|May 26, 2004
Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injuryLavinia M Proctor, Thiruma V Arumugam, Ian Shiels, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2012
C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signalingJunxian Lim, Abishek Iyer, Jacky Y Suen, et al.
Journal of Medicinal Chemistry|December 4, 2014
Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulenceWilko Duprez, Lakshmanane Premkumar, Maria A Halili, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel diseaseTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2010
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID componentsNicole C Wheatley, Katherine T Andrews, Truc L Tran, et al.
The Journal of Surgical Research|January 21, 2004
Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in ratsTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2016
An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in MiceAnh Do, Robert C Reid, Rink-Jan Lohman, et al.
Journal of Innate Immunity|March 7, 2023
Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human MacrophagesKai-Chen Wu, Nicholas D Condon, Timothy A Hill, et al.
Journal of Medicinal Chemistry|September 30, 2010
Novel agonists and antagonists for human protease activated receptor 2Grant D Barry, Jacky Y Suen, Giang T Le, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive ratsScott Levick, David Loch, Barbara Rolfe, et al.
British Journal of Pharmacology|May 26, 2004
Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injuryLavinia M Proctor, Thiruma V Arumugam, Ian Shiels, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2012
C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signalingJunxian Lim, Abishek Iyer, Jacky Y Suen, et al.
Journal of Medicinal Chemistry|December 4, 2014
Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulenceWilko Duprez, Lakshmanane Premkumar, Maria A Halili, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel diseaseTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2010
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID componentsNicole C Wheatley, Katherine T Andrews, Truc L Tran, et al.
The Journal of Surgical Research|January 21, 2004
Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in ratsTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Pageof 8